A clinical hepatologist's predictions about non-absorbed carbohydrates for the early twenty-first century

Scandinavian Journal of Gastroenterology, Supplement

Volumn 32, Issue 222, 1997, Pages 88-92

  Conn, H O ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c NONE   (United States)

Author keywords

cholesterol gallstones; colonic carcinoma; constipation; endotoxins; hepatic encephalopathy; lactitol; lactulose; Salmonella carrier state; Shigella carrier state; subclinical hepatic encephalopathy

Indexed keywords

LACTITOL; LACTULOSE; URSODEOXYCHOLIC ACID; GASTROINTESTINAL AGENT; LAXATIVE;

COLON CARCINOMA; CONSTIPATION; GALLSTONE; HEPATIC ENCEPHALOPATHY; HUMAN; PRIORITY JOURNAL; REVIEW; FORECASTING; GASTROENTEROLOGY;

CATHARTICS; FORECASTING; GASTROENTEROLOGY; GASTROINTESTINAL AGENTS; HEPATIC ENCEPHALOPATHY; HUMANS; LACTULOSE;

EID: 0030949813     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. Montgomery E, Hudson CS. Transformation of lactose to a new disaccharide, lactoketose. Science 1929;69:556.
2. Ingelfinger F. Editorial comments. In: Beeson PB et al, editors. Year book of medicine. Chicago: Year Book Medical Publishers 1964-1965:591-2.
3. Bircher J, Gmünder U, Haemmerli UP, Haemmerli G, Bally G, Muller-Duysing W, Hoffmann K. Determination of colonic bacterial flora and urease activity during lactulose therapy in rats. Symposium on Lactulose. Baden bei Wein, Austria, September 8, 1969..
4. Huffman K, Bircher J, Haemmerli UP. Correlation of changes in fecal flora, fecal pH and fecal ammonia. Symposium on Lactulose. Baden bei Wein, Austria, September 8, 1969..
5. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double-blind controlled trial. Gastroenterology 1977;72:573-83.
6. Heredia D, Caballen'a J, Arroyo V, et al. Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE): a controlled trial. J Hepatol 1987;4:293-8.